CLR1501 

CLR1501, a fluorescently labeled CLR1404 analog, is a cancer cell-selective fluorescence compound^[1][2].

CLR1501 exhibits five- to ninefold preferential uptake in these cancer cell lines in vitro compared to normal fibroblasts^[1].
Excitation/emission peaks are 500/517 nm for CLR1501. CLR1501 exhibits tumor selectivity in vitro and in vivo for human glioblastoma stem-like (GSC) cell lines and xenografts^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

701.67

C₃₈H₅₉BF₂N₃O₄P

1250963-36-0

Oil

Brown to reddish brown

[F-][B+3]1([N-]2C(C(C3=CC=C(CCCCCCCCCCCCCCCCCCOP(OCC[N+](C)(C)C)([O-])=O)C=C3)=C4[N]1=CC=C4)=CC=C2)[F-]

Room temperature in continental US; may vary elsewhere.

-20°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

• [1]. Weichert JP, et al. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy. Sci Transl Med. 2014 Jun 11;6(240):240ra75.  [Content Brief]

  [2]. Swanson KI, et al. Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection. Neurosurgery. 2015 Feb;76(2):115-23; discussion 123-4.  [Content Brief]

  [3]. Deming DA, Maher ME, Leystra AA, et al. Phospholipid ether analogs for the detection of colorectal tumors. PLoS One. 2014;9(10):e109668.  [Content Brief]